See a health care provider promptly if any of the following symptoms appear:
After completion of treatment, the diagnostic studies are repeated to see how the treatment has affected the leukemia. Many people have a reduction or even a disappearance of leukemia cells in their blood and bone marrow. This is called remission.
Another factor to be addressed may be impaired organ function secondary to therapy. Careful follow-up on any patient who has received extensive therapy, such as stem cell transplantation, should receive careful systemic evaluations in order to initiate corrective measures should any organ impairment be detected.
No known way exists to prevent leukemia. Avoiding risk factors such as smoking, exposure to toxic chemicals, and exposure to radiation may help prevent some cases of leukemia.
The leukemias vary in their response to treatment.
Specific factors are associated with outcomes in each type of leukemia. General factors associated with outcomes include the following:
Like other cancers, leukemia outlook is measured in terms of survival rates. The number of people who are still alive 5 years after treatment varies by type of leukemia. After 5 years, greater than 80% of patients without detectable disease will likely maintain a lifelong remission. Patients in remission longer than 15 years are considered unequivocal cures.
One problem that requires concerted efforts by advocate groups is the need to address the reluctance on the part of the health care industry to offer health insurance for former pediatric leukemia patients whose disease-free survivals are considered "cures" by all available evidence.
Click below to see more videos....